Biological Material Transfer Agreement Template for the Netherlands

Generate a bespoke document

What is a Biological Material Transfer Agreement?

The Biological Material Transfer Agreement (MTA) is a crucial legal instrument used in the Netherlands for controlling and documenting the transfer of biological materials between organizations. This document becomes necessary when research institutions, companies, or other entities need to share biological materials for research, development, or commercial purposes. It operates within the framework of Dutch law and EU regulations, particularly addressing requirements under EU Regulation 511/2014 and the Nagoya Protocol. The agreement typically covers various aspects including material identification, permitted uses, intellectual property rights, confidentiality, and regulatory compliance. It's particularly important in ensuring proper documentation of material origin, maintaining chain of custody, and establishing clear rights and responsibilities for both providers and recipients of biological materials.

Trusted by high-performance teams

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Jurisdiction

Netherlands

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Biological Material Transfer Agreement

A Biological Material Transfer Agreement is a specialized contract that governs the transfer of biological materials between organizations in the Netherlands. You need this document whenever you're sharing or receiving biological specimens, genetic resources, cell lines, or other biological materials for research, development, or commercial purposes. The agreement establishes legal boundaries and protections while ensuring compliance with both Dutch national law and European Union regulations.

When do you need this document?

You require a Biological Material Transfer Agreement when transferring biological materials between research institutions, universities, biotech companies, or pharmaceutical organizations. This includes scenarios such as sharing cell cultures for collaborative research projects, transferring genetic samples for drug development, providing biological specimens for clinical trials, or distributing materials from biobanks to research centers. The agreement is also essential when academic institutions collaborate with commercial entities, ensuring that intellectual property rights and commercial interests are properly protected. Additionally, you need this document when transferring materials internationally, as it helps demonstrate compliance with the Nagoya Protocol and facilitates proper documentation of genetic resource origins.

Key legal considerations

Your agreement must clearly define the scope of permitted uses, distinguishing between research and commercial applications. You should address intellectual property ownership, particularly regarding any discoveries, inventions, or modifications derived from the transferred materials. Publication rights and confidentiality obligations require careful consideration, especially when sensitive research data or proprietary materials are involved. The agreement should specify liability limitations and indemnification clauses to protect both parties from potential legal risks. You must also include provisions for regulatory compliance, ensuring that all parties understand their obligations under applicable biosafety and environmental regulations. Consider including termination clauses that address the return or destruction of materials and any derived products.

Legal requirements in Netherlands

Under Netherlands law, your Biological Material Transfer Agreement must comply with EU Regulation 511/2014, which implements the Nagoya Protocol on genetic resources and benefit-sharing. You're required to maintain due diligence documentation demonstrating legal acquisition of genetic resources and associated traditional knowledge. The Dutch Act on Patents governs intellectual property rights arising from biological materials, requiring clear agreements on ownership and licensing of any resulting innovations. GDPR compliance is mandatory when biological materials contain personal genetic data, necessitating appropriate data protection measures and consent procedures. The Dutch Environmental Management Act may apply to certain biological transfers, particularly those involving genetically modified organisms or potentially hazardous materials. You must also consider the Genetically Modified Organisms Decree if your materials fall under GMO regulations, ensuring proper authorization and containment measures are documented in your agreement.

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it